PENTAGLOBIN  LİTERATÜR  LİSTESİ
 
  KONULAR
  NEONATAL SEPSIS - A
  CARDIAC SURGERY
  BASIC RESEARCH - A
  BMT
  ANAESTHESIOLOGY-A
  COMPLEMENT-INHIBITOR
  ENDOTOXIN
  ENDOTOXIN NEUTRALIZATION    
  GVHD
  COCHRANE
  ADULT-SEPSIS-A
  HYDROCORTİSONE
  G-LEVEL
  IN-VITRO
  IN_VIVO
  INTERNAL MEDICINE
  SEPTIC SHOCK
  STREPTOCOCCAL SUPERANTIGEN    
  SURGERY
  TRANSPLANTATION
  UNCONTROLLED STUDY
  PENTAGLOBIN IS SUPERIOR TO IgG    
  PNEUMONIA
  PREVENTIVE
  REVIEW
  SEPSIS
  LEEUKAEMIA
  MENINGOCOCCAL SEPSIS
  META  ANATYSIS
  MORTALITY
  ONCOLOGY
  OPERATIVE ICV
  PAEDIATRICS
  CONTROLLED STUDY
 
  NEONATAL SEPSIS - A
ID LİTERATÜR İSMİ YAZAR TARİH
28 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Haque 1988
31 Comparison of two types of intravenous immunoglobulin in the treatment of neonatal sepsis Haque 1995
104 Immunoglobulin - Infusion in der Therapie der neonatalen Sepsis  Seitz 1995
110 IgM - Enriched Intravenous Immunoglobulizn in the treatment of Neonatal Sepsis  Helwege 1997
143 Passive Immuntherapie und - prophylaxe Belohraosky 2000
 
  CARDIAC SURGERY
ID LİTERATÜR İSMİ YAZAR TARİH
134 Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M -enriched preparation in anergic patients undergoing cardiac surgery Kress 1999
126 Effects of early treatment with immunoglobulin on critical illness poly neuropathy following multiple organ failure and gram - negative sepsis    Mohr 1997
 
  BASIC RESEARCH - A
ID LİTERATÜR İSMİ YAZAR TARİH
8 Experimentelle Grundlagen der Endotoxin - Neutralisation durch polyklonale und polyvalente Immunoglobuline   Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
120 Bacterial LPS - Specific antibodies in commercial human immunoglobulin preparations :superior antibody content of an IgM -enriched product Trautmann 1998
122 Immunoglobulin M -Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation Rieben 1999
127 Anreicherung LPS-Spezifischer antibakterieller Antikörper in einem IgM-haltigen intrave nösen Immunglobulin preparat Trautmann 1998
128 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 1998
133 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 1999
151 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 2000
152 IgM- Enriched Intravenous Immunglobulin:Antiinflamatory Therapy by Complement Inhibition Rıeben 2000
 
  BMT
ID LİTERATÜR İSMİ YAZAR TARİH
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 Use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
132 Use of a five-GVHD prevention regimen in recipients of unrelated donor marrow Zander 1999
 
  ANAESTHESIOLOGY-A
ID LİTERATÜR İSMİ YAZAR TARİH
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Briegel 1999
 
  COMPLEMENT-INHIBITOR
ID LİTERATÜR İSMİ YAZAR TARİH
122 Immunoglobulin M -Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation Rıeben 1999
152 IgM- Enriched Intravenous Immunglobulin:Antiinflamatory Therapy by Complement Inhibition Rıeben 2000
 
  ENDOTOXIN
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulins Behre 1992
8 Experimentelle Grundlagen der Endotoxin - Neutralisation durch polyklonale und polyvalente  Immunoglobuline   Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 Use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
106 Endotoxin Concentrations and Therapy with Polyclonal IgM-Enriched Immunoglobulins  in Neutropenic Cancer Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
120 Bacterial LPS - Specific antibodies in commercial human immunoglobulin preparations :superior antibody content of an IgM -enriched product Trautmann 1998
127 Anreicherung LPS-Spezifischer antibakterieller Antikörper in einem IgM-haltigen intrave nösen Immunglobulin preparat Trautmann 1998
 
  ENDOTOXIN NEUTRALIZATION
ID LİTERATÜR İSMİ YAZAR TARİH
8 Experimentelle Grundlagen der Endotoxin - Neutralisation durch polyklonale und polyvalente Immunoglobuline   Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 Use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
106 Endotoxin Concentrations and Therapy with Polyclonal IgM-Enriched Immunoglobulins in Neutropenic Cancer Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
 
  GVHD
ID LİTERATÜR İSMİ YAZAR TARİH
132 Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow Zander 1999
 
  COCHRANE
ID LİTERATÜR İSMİ YAZAR TARİH
135 Intravenous immunoglobulin for treating sepsis and septic shock Alejandria 1999
 
  ADULT-SEPSİS-A
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation with Clinical Outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulins Behre 1992
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
106 Endotoxin Concentrations and Therapy with Polyclonal IgM-Enriched Immunoglobulins in Neutropenic Cancer Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
126 Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram - negative sepsis    Mohr 1997
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Briegel 1999
 
  HYDROCORTİSONE
ID LİTERATÜR İSMİ YAZAR TARİH
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Briegel 1999
 
  G-LEVEL
ID LİTERATÜR İSMİ YAZAR TARİH
28 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Haque 1988
 
  IN-VITRO
ID LİTERATÜR İSMİ YAZAR TARİH
8 Experimentelle Grundlagen der Endotoxin - Neutralisation durch polyklonale und polyvalente Immunoglobuline   Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
120 Bacterial lipopolysaccharide LPS - Specific antibodies in commercial human immunoglobulin preparations :superior antibody content of an IgM-enriched product Trautmann 1998
122 Immunoglobulin M -Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation Rıeben 1999
127 Anreicherung LPS-Spezifischer antibakterieller Antikörper in einem IgM-haltigen intrave nösen Immunglobulin preparat Trauttmann 1998
128 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 1998
133 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 1999
151 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby 2000
152 IgM- Enriched Intravenous Immunglobulin:Antiinflamatory Therapy by Complement Inhibition Rıeben 2000
 
  IN-VIVO
ID LİTERATÜR İSMİ YAZAR TARİH
8 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
122 Immunoglobulin M -Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation Rıeben 1999
152 IgM- Enriched Intravenous Immunglobulin:Antiinflamatory Therapy by Complement Inhibition Rıeben 2000
 
  INTERNAL MEDICINE
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulins Behre  1992
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel  1991
106 Endotoxin Concentrations and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre  1995
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
129 Therapy with Polyclonal Igm-Enriched Immunoglobulin In Pediatric Patients with Severe Sepsis Syndrome :A Retrospective Evaluation Mertens 1998
 
  SEPTIC SHOCK
ID LİTERATÜR İSMİ YAZAR TARİH
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
126 Effects of early treatment with immunoglobulin on critical illness ployneuropathy following multiple organ failure and gram - negative sepsis    Mohr 1997
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Brıegel 1999
 
  STREPTOCOCCAL SUPERANTIGEN
ID LİTERATÜR İSMİ YAZAR TARİH
128 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby  1998
133 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby  1999
151 Polyspecific IgM  and IgA inhibit Group A streptococcal Superantigen-Induced T Cell Proliferation and Cytokine Production. Norrby  2000
 
  SURGERY
ID LİTERATÜR İSMİ YAZAR TARİH
134 Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M -enriched preparation in anergic patients undergoing cardiac surgery Kress 1999
 
  TRANSPLANTATION
ID LİTERATÜR İSMİ YAZAR TARİH
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
132 Use of a five-GVHD prevention regimen in recipients of unrelated donor marrow Zander 1999
 
  UNCONTROLLED STUDY
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulin Behre 1992
106 Endotoxin Concentration and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
132 Use of a five-GVHD prevention regimen in recipients of unrelated donor marrow Zander 1999
 
  PENTAGLOBIN IS SUPERIOR TO IgG
ID LİTERATÜR İSMİ YAZAR TARİH
8 Experimentele Grundlagen der Endotoxin - Neutralisation durch polyklone und ployvalent Immunoglobulin   Berger 1991
9 Anti-endotoxic therapy with polyclonal and polyvalent immunoglobulins:İn-vitro and in-vivo studies Berger 1991
31 Comparison of two types of intravenous immunoglobulin in the treatment of neonatal sepsis Haque 1995
120 Bacterial LPS - Specific antibodies in commercial human immunoglobulin preparations :superior antibody content of an gem -enriched product Trauttmann 1998
122 Immunoglobulin M -Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation Rıeben 1999
135 Intravenous immunoglobulin for treating sepsis and septic shock Alejandrıa 1999
152 IgM- Enriched Intravenous Immunglobulin:Antiinflamatory Therapy by Complement Inhibition Rıeben 2000
127 Anreicherung LPS-Spezifischer antibakterieller Antikörper in einem IgM-haltigen intrave nösen Immunglobulin preparat Trauttmann 1998
 
  PNEUMONIA
ID LİTERATÜR İSMİ YAZAR TARİH
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
 
  PREVENTIVE
ID LİTERATÜR İSMİ YAZAR TARİH
134 Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M -enriched preparation in anergic patients undergoing cardiac surgery Kress 1999
 
  REVIEW
ID LİTERATÜR İSMİ YAZAR TARİH
143 Passive Immuntherapie und - prophylaxe Belohradsky 2000
 
  SEPSIS
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulin Behre 1992
28 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Haque 1988
31 Comparison of two types of intravenous immunoglobulin in the treatment of neonatal sepsis Haque 1995
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
104 Immunoglobulin - Infusion in der Therapie der neonatalen Sepsis  Seıtz 1995
106 Endotoxin Concentration and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
110 Igm - Enriched Intravenous Immunoglobulin in the treatment of Neonatal Sepsis  Hellwege 1997
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
126 Effects of early treatment with immunoglobulin on critical illness ployneuropathy following multiple organ failure and gram - negative sepsis    Mohr 1997
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Briegel 1999
143 Passive Immuntherapie und - prophylaxe Belohradsky 2000
 
  LEEUKAEMIA
ID LİTERATÜR İSMİ YAZAR TARİH
106 Endotoxin Concentration and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
 
  MENINGOCOCCAL SEPSIS
ID LİTERATÜR İSMİ YAZAR TARİH
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
 
  META  ANATYSIS
ID LİTERATÜR İSMİ YAZAR TARİH
135 Intravenous immunoglobulin for treating sepsis and septic shock Alejandrıa 1999
 
  MORTALITY
ID LİTERATÜR İSMİ YAZAR TARİH
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
 
  ONCOLOGY
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulin Behre 1992
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
106 Endotoxin Concentration and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
 
  OPERATIVE ICV
ID LİTERATÜR İSMİ YAZAR TARİH
134 Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M -enriched preparation in anergic patients undergoing cardiac surgery Kress 1999
139 Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective , randomized ,double-blind ,single-center study Briegel 1999
 
  PAEDIATRICS
ID LİTERATÜR İSMİ YAZAR TARİH
28 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Haque 1988
31 Comparison of two types of intravenous immunoglobulin in the treatment of neonatal sepsis Haque 1995
104 Immunoglobulin - Infusion in der Therapie der neonatalen Sepsis  Seıtz 1995
110 Igm - Enriched Intravenous Immunoglobulin in the treatment of Neonatal Sepsis  Hellwege 1997
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
143 Passive Immuntherapie und - prophylaxe Belohradsky 2000
 
   CONTROLLED STUDY
ID LİTERATÜR İSMİ YAZAR TARİH
4 Endotoxin Concentration in Neutropenic Patients with Suspected Gram-Negative Sepsis: Correlation With Clinical outcome and Determination of Anti-Endotoxin Core Antibodies during Therapy with Polyclonal Immunoglobulin M-Enriched Immunoglobulin Behre 1992
28 IgM - Enriched Intravenous Immunoglobulin  Therapy in Neonatal Sepsis  Haque 1988
31 Comparison of two types of intravenous immunoglobulin in the treatment of neonatal sepsis Haque 1995
67 IgM Enriched Immunoglobulin (Pentaglobin) and Endotoxaemia in Marrow Transplant Patients Poynton 1990
69 use of IgM enriched intravenous immunoglobulin ( Pentaglobin ) in bone marrow transplantation  Poynton 1992
76 Treatment of Gram-Negative septic shock with an immunoglobulin preparation: A prospective , randomized clinical trial Schedel 1991
104 Immunoglobulin - Infusion in der Therapie der neonatalen Sepsis  Seıtz 1995
106 Endotoxin Concentration and Therapy with Polyclonal IgM-Enriched Immunoglobulin in Neutropenic Cancel Patients with Sepsis Syndrome :Pilot study and Interim Analysis of a Randomized Trial Behre 1995
110 Igm - Enriched Intravenous Immunoglobulin in the treatment of Neonatal Sepsis  Hellwege 1997
111 Beobachtete und vorhergesagte Mortalitat bei Patienten mit schwerer Sepsis und septischem Schock Kreymann 1997
126 Effects of early treatment with immunoglobulin on critical illness ployneuropathy following multiple organ failure and gram - negative sepsis    Mohr 1997
129 Therapy with Polyclonal IgM-Enriched Immunoglobulin in Pediatric Patients with severe Sepsis Syndrome :A Retrospective Evaluation  Mertens 1998
132 Use of a five-GVHD prevention regimen in recipients of unrelated donor marrow Zander 1999
134 Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M -enriched preparation in anergic patients undergoing cardiac surgery Kress 1999